Marion Rubis
Publications by Year
Research Areas
Galectins and Cancer Biology, Glycosylation and Glycoproteins Research, Toxin Mechanisms and Immunotoxins, Wnt/β-catenin signaling in development and cancer, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions(2017)395 cited
- → Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness(2016)206 cited
- → Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts(2017)195 cited
- → TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma(2021)90 cited
- → Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer(2020)80 cited
- → Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ 1: implications for individualized medicine efforts(2017)68 cited
- → Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression(2022)66 cited
- → A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis(2021)42 cited
- → Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma(2017)29 cited
- → A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma(2022)23 cited